Checkpoint Therapeutics, Inc. Profile Avatar - Palmy Investing

Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candi…

Biotechnology
US, Waltham [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Checkpoint Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Checkpoint Therapeutics, Inc. has no acquisition track records yet.

End of CKPT's Analysis
CIK: 1651407 CUSIP: 162828107 ISIN: US1628282063 LEI: - UEI: -
Secondary Listings
CKPT has no secondary listings inside our databases.